Dilution of Share Value from Exercise of Stock Options
First written in FY2016. 21 of 24 entries say "Materialised", first in FY2020-Q1. Latest entry: FY2026-H1.
Members moved to the "Worse" side of this theme in 2019, 1 year before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 1,600 13,423,300 1,596 1,078,881 1,596 709,344 (Note) Increase resulting from the exercise of stock acquisition rights. Number of stock acquisition rights (units) ※ 32,750 Class, details and number of shares underlying the stock acquisition rights (shares) ※ Common shares 327,500」
In addition to the issuance of 1,600 shares during the interim period through the exercise of stock acquisition rights, new stock acquisition rights were issued for 327,500 common shares, sustaining and adding to the potential for dilution. - FY2025-H1MaterialisedAnnual report
「Number of stock acquisition rights (units) ※ 16,855 Class, details and number of shares underlying the stock acquisition rights (shares) ※ Common shares 168,550」
On 19 July 2024, stock acquisition rights were issued for 168,550 common shares, adding to the potential future dilution of equity value upon exercise. - FY2024MaterialisedAnnual report
「1 April 2023–31 March 2024 (Note) 58,000 13,421,700 51,991 1,077,285 51,991 707,748 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the fiscal year, the number of shares increased by 58,000 through the exercise of stock acquisition rights, and the increase in the number of shares through the exercise of stock options continued. - FY2024-Q2MaterialisedAnnual report
「Increase during the period (Note) 58,000 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the six-month period, the number of issued shares increased by 58,000 through the exercise of stock acquisition rights. Share issuance through the exercise of stock options and the potential dilution of equity value continue to materialise. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 57,800 13,421,500 51,792 1,077,085 51,792 707,548 (Note) 1. The increase resulted from the exercise of stock acquisition rights.」
During the quarter, the number of issued shares increased by 57,800 through the exercise of stock acquisition rights, as the potential dilution of equity value continued to materialise through actual share issuance. - FY2023MaterialisedAnnual report
「1 April 2022–31 March 2023 (Note) 1 145,800 13,363,700 60,307 1,025,293 60,307 655,756 (Note) 1. The increase resulted from the exercise of stock acquisition rights.」
During the fiscal year, the number of shares increased by 145,800 through the exercise of stock acquisition rights, while share issuance through the exercise of stock options and the potential for dilution continued to materialise as an actual increase in the number of shares. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 1,100 13,362,900 1,070 1,024,556 1,070 655,019 (Note) 1. Increase due to the exercise of share acquisition rights. 2. Between 1 January 2023 and 31 January 2023, the number of issued shares increased by 200 through the exercise of share acquisition rights, while stated capital and capital surplus each increased by ¥199 thousand.」
During the third-quarter accounting period, the number of shares increased by 1,100 through the exercise of stock acquisition rights, and a further increase of 200 shares in January 2023, before the filing, was also recorded. - FY2023-Q2MaterialisedAnnual report
「1 July 2022–30 September 2022 15,400 13,361,800 16,898 1,023,485 16,898 653,948 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the second quarter accounting period, 15,400 shares were issued through the exercise of share acquisition rights. The increase during the period from April to September 2022 was 143,900 shares, and an additional increase of 600 shares in October before the filing was disclosed. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 128,500 13,346,400 41,601 1,006,587 41,601 637,050 (Note) 1. Increase due to the exercise of share acquisition rights. 2. Between 1 July 2022 and 31 July 2022, the number of issued shares increased by 14,300 through the exercise of share acquisition rights, while stated capital and capital surplus each increased by ¥15,717 thousand.」
During the first quarter, the number of issued shares increased by 128,500 through the exercise of share acquisition rights, and an additional increase of 14,300 shares in July before the filing was disclosed. Share issuance through stock-option exercise continued. - FY2022MaterialisedAnnual report
「1 April 2021–31 March 2022 (Note) 1 237,600 13,217,900 53,797 964,986 53,797 595,449 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the fiscal year, 237,600 shares were issued through the exercise of share acquisition rights, and share issuance through stock-option exercise and the potential for dilution materialised as a substantial increase in the number of shares. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 2,500 13,132,300 742 937,651 742 568,114 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the third quarter accounting period, 2,500 shares were issued through the exercise of share acquisition rights. An additional increase of 200 shares by the filing date was also disclosed, indicating that share issuance through exercise continued. - FY2022-Q2MaterialisedAnnual report
「Change in total number of issued shares (shares) 149,000 (Note) 1. Increase due to the exercise of share acquisition rights.」
From April to September 2021, 149,500 shares were issued through the exercise of share acquisition rights. Additional increases of 500 shares from July to September and 200 shares in October were also disclosed, indicating that the potential for dilution continued to materialise as actual share issuance. - FY2022-Q1MaterialisedAnnual report
「Change in total number of issued shares (shares) 149,000 (Note) 1. Increase due to the exercise of share acquisition rights.」
From April to June 2021, 149,000 shares were issued through the exercise of share acquisition rights, and the potential dilution of share value from stock-option exercise materialised as actual share issuance. - FY2021MaterialisedAnnual report
「1 April 2020–31 March 2021 (Note) 1 42,200 12,980,300 9,911 910,405 9,911 541,652 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the fiscal year, 42,200 shares were issued through the exercise of share acquisition rights, and the potential dilution of share value continued to materialise as actual share issuance. - FY2021-Q3MaterialisedAnnual report
「1 October 2020–31 December 2020 2,400 12,946,800 1,220 904,803 1,220 535,266 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the third quarter accounting period, 2,400 shares were issued through the exercise of share acquisition rights. An additional increase of 31,400 shares in January 2021 was also disclosed, indicating that share issuance through stock-option exercise continued. - FY2021-Q2MaterialisedAnnual report
「Increase during the period (Note) 6,300 (Note) Increase due to the exercise of stock options.」
During the six-month period of the second quarter of the fiscal year, the total number of issued shares increased by 6,300 through the exercise of share acquisition rights, and the potential for dilution continued to materialise as actual share issuance. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 1,100 12,939,200 349 901,627 349 532,090 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the first quarter, 1,100 shares were issued through the exercise of share acquisition rights. An additional increase of 1,700 shares in July 2020 was also disclosed, indicating that share issuance through exercise continued. - FY2020MaterialisedAnnual report
「1 April 2019–31 March 2020 (Note) 1 60,400 12,938,100 15,849 901,277 15,849 531,740 (Note) 1. Increase due to the exercise of share acquisition rights.」
During the fiscal year, 60,400 shares were issued through the exercise of share acquisition rights, and the potential dilution of share value continued to materialise as actual share issuance. - FY2020-Q3MaterialisedAnnual report
「1 October 2019–31 December 2019 24,200 12,937,500 4,884 901,033 4,884 531,496 (Note) Increase due to the exercise of share acquisition rights.」
During the third quarter accounting period, 24,200 shares were issued through the exercise of share acquisition rights, bringing the increase during the period from April to December 2019 to 59,800 shares. Share issuance through stock-option exercise and the potential for dilution continued to materialise. - FY2020-Q2MaterialisedAnnual report
「Increase in total number of issued shares during the period (Note) 35,600 (Note) Increase due to the exercise of stock options.」
From April to September 2019, the total number of issued shares increased by 35,600 through the exercise of share acquisition rights, and the potential dilution from stock-option exercise continued to materialise as actual share issuance. - FY2020-Q1MaterialisedAnnual report
「Change in total number of issued shares (shares) 33,400 (Note) 1. Increase due to the exercise of share acquisition rights.」
From April to June 2019, 33,400 shares were issued through the exercise of share acquisition rights, and the potential dilution of share value from stock-option exercise materialised as actual share issuance. - FY2018RestatedAnnual report
「If stock options currently issued or issued in the future are exercised, the total number of issued shares may increase and the value per share may be diluted, and this dilution in per-share value may affect share-price formation.」
It reiterates the risk of an increase in issued shares and dilution of per-share value resulting from the exercise of stock options. - FY2017RestatedAnnual report
「If stock options currently issued or issued in the future are exercised, the total number of issued shares may increase and the value per share may be diluted, and this dilution in per-share value may affect share-price formation.」
It reiterates the risk of an increase in issued shares and dilution of per-share value resulting from the exercise of stock options. - FY2016First statedAnnual report
「If stock options currently issued or issued in the future are exercised, the total number of issued shares may increase and the value per share may be diluted, and this dilution in per-share value may affect share-price formation.」
It identifies the increase in issued shares and dilution of per-share value resulting from the exercise of share acquisition rights as risks to shareholders.